Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis
Authors:
- Pipit BurasakarnPBPipit Burasakarn
- Masakazu YamamotoMasakazu Yamamoto
- Japan Duodenal Cancer Guideline CommitteeJCJapan Duodenal Cancer Guideline Committee
- S. N. Souya NunobeSNS. N. Souya Nunobe
- S. K. Shingo KanajiSKS. K. Shingo Kanaji
- H. E. Hidetoshi EguchiHEH. E. Hidetoshi Eguchi
- K. O. Ken-Ichi OkadaKOK. O. Ken-Ichi Okada
- T. F. Tsutomu FujiiT. F. Tsutomu Fujii
- Y. N. Yuichi NagakawaYNY. N. Yuichi Nagakawa
- K. K. Kengo KanetakaKKK. K. Kengo Kanetaka
- H. Y. Hiroharu YamashitaH. Y. Hiroharu Yamashita
- S. Y. Suguru YamadaSYS. Y. Suguru Yamada
- 1 January 2021
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 26 (3) , 450-460
Abstract
It is well known that surgery is the mainstay treatment for duodenal adenocarcinoma. However, the optimal extent of surgery is still under debate. We aimed to systematically review and perform a meta-analysis of limited resection (LR) and pancreatoduodenectomy for patients with duodenal adenocarcinoma. A systematic electronic database search of the literature was performed using PubMed and the Cochrane Library. All studies comparing LR and pancreatoduodenectomy for patients with duodenal adenocarcinoma were selected. Long-term overall survival was considered as the primary outcome, and perioperative morbidity and mortality as the secondary outcomes. Fifteen studies with a total of 3166 patients were analyzed; 995 and 1498 patients were treated with limited resection and pancreatoduodenectomy, respectively. Eight and 7 studies scored a low and intermediate risk of publication bias, respectively. The LR group had a more favorable result than the pancreatoduodenectomy group in overall morbidity (odd ratio [OR]: 0.33, 95% confidence interval [CI] 0.17–0.65) and postoperative pancreatic fistula (OR: 0.13, 95% CI 0.04–0.43). Mortality (OR: 0.96, 95% CI 0.70–1.33) and overall survival (OR: 0.61, 95% CI 0.33–1.13) were not significantly different between the two groups, although comparison of the two groups stratified by prognostic factors, such as T categories, was not possible due to a lack of detailed data. LR showed long-term outcomes equivalent to those of pancreatoduodenectomy, while the perioperative morbidity rates were lower. LR could be an option for selected duodenal adenocarcinoma patients with appropriate location or depth of invasion, although further studies are required.Keywords
Funding Information
- Health and Labor Sciences Research Grant (H29-GANTAISAKU-IPPAN-013)
- JSPS KAKENHI (18K08632)
This publication has 60 references indexed in Scilit:
- 15-Year Experience with Surgical Treatment of Duodenal Carcinoma: a Comparison of Periampullary and Extra-Ampullary Duodenal CarcinomasJournal of Gastrointestinal Surgery, 2012
- Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for TreatmentAnnals of Surgical Oncology, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Prognostic Factors Associated with Survival in Patients with Primary Duodenal AdenocarcinomaThe Korean Journal of Internal Medicine, 2011
- Surgical management of benign duodenal tumours*Anz Journal of Surgery, 2010
- Assessment of Complications After Pancreatic SurgeryAnnals of Surgery, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Adenocarcinoma of the Duodenum: Importance of Accurate Lymph Node Staging and Similarity in Outcome to Gastric CancerAnnals of Surgical Oncology, 2004
- Health care in developing countriesThe Lancet, 1992
- EFFECTS OF PHYSICAL ACTIVITY ON RISK FACTORS FOR CORONARY HEART DISEASE IN PREVIOUSLY SEDENTARY WOMEN: A FIVE‐YEAR LONGITUDINAL STUDYAustralian and New Zealand Journal of Medicine, 1988